Zoetis is trading 4.01% up at $78.03, with the gain aligned with healthcare-sector strength.

  • XLV is up 1.29%, alongside modestly positive major indexes and broader risk appetite.
  • No fresh company-specific announcement surfaced for August 21, 2026.
  • Zoetis cut its 2026 outlook on August 6 amid softer pet-healthcare demand and increased competition; that earlier catalyst does not directly explain the current gain.